HELMD Drive vs. Ro Sparks: How Do They Compare?

HELMD Drive bottle and sublingual tablet next to a Ro Sparks pouch and tablet

HELMD Drive and Ro Sparks are both compounded sublingual tablets and share the same two PDE5 inhibitors, sildenafil (generic Viagra®) and tadalafil (generic Cialis®). (Note: Ro sells many other ED treatments; Sparks is the strongest.)

HELMD Drive's biggest differentiator is its third pharmaceutical, apomorphine. Apomorphine targets the brain's arousal pathway with placebo-controlled evidence for ED treatment6, 7; Ro Sparks contains only the two ingredients focused on blood flow.

These sublingual tablets both dissolve under the tongue and both kicked in within 15 minutes in testing4, 5. HELMD Drive comes in two strengths, while Ro Sparks is one fixed dose for everyone, 55mg sildenafil and 22mg tadalafil1. Drive is significantly cheaper: $7.67 per tablet for Drive versus $11.17 for Sparks on the same plan3. Finally, Drive also contains no artificial colors or dyes.

In 2026 head-to-head testing, two review publications, The Customer Digest and Protocol Man, both rated HELMD Drive first among combination ED treatments; both articles included Ro Sparks4, 5. Here's how they stack up.

Key takeaways

  • What's the real difference? Dosage strength and ingredients: both pair sildenafil and tadalafil; Drive adds apomorphine, a brain-pathway agent with placebo-controlled evidence for ED treatment6, 7, while Sparks has no third active.
  • Same format, different dosing: both are sublingual tablets that kicked in within 15 minutes in testing4, 5; Drive offers two strengths, Sparks one fixed dose1.
  • What about price? On the same plan (3 months at 6 doses per month), Drive comes to $7.67 per tablet at checkout and Sparks to $11.173.
  • Provider-reviewed: Both are compounded formulations, not FDA-approved; both require an online visit and a provider's review.
Quick note: This article is for informational purposes only and is not medical advice or an endorsement of one brand over another. Both products are compounded medications, which are not approved by the FDA. Always talk to a licensed provider about what's right for you. Pricing and products are accurate as of November 20, 2026, where possible.
On this page

Quick comparison

 FeatureHELMD DriveRo Sparks
FormatCompounded sublingual tablet (dissolves under the tongue)Compounded sublingual tablet (dissolves under the tongue)
OnsetAs short as 15 minutes8As short as 15 minutes1, 4, 5
PharmaceuticalsSildenafil + tadalafil + apomorphine. Two strengths: 65/20/2 and 80/20/3 (mg sildenafil / tadalafil / apomorphine)Sildenafil + tadalafil only. One fixed dose: 55mg / 22mg; 22mg exceeds the 20mg FDA-approved maximum1, 11
MechanismsBlood flow (PDE5) + brain arousal pathwayBlood flow (PDE5) only
FDA statusCompounded: not FDA-approvedCompounded: not FDA-approved
AvailabilityU.S. except South CarolinaConfirm at checkout for your state
Cost$7.67/tablet (6 doses / mo, 3 month plan)3$11.17/dose at checkout, same plan; $12 billed monthly (September 2026)3

The products

Both companies deliver their ED treatment as a tablet that dissolves under the tongue rather than a pill you swallow.

Sildenafil and tadalafil are first-line ED treatments with strong clinical support9. And in a study of 180 men, pairing them produced higher erectile function scores than tadalafil alone10.

HELMD Drive

HELMD Drive is a compounded sublingual tablet that combines sildenafil and tadalafil (two PDE5 inhibitors) with apomorphine, a dopamine agonist. Apomorphine acts on the brain's arousal pathways and has clinical evidence for ED6, 7. It comes in two strengths: Drive (sildenafil 65mg, tadalafil 20mg, apomorphine 2mg) and Drive Max (sildenafil 80mg, tadalafil 20mg, apomorphine 3mg). You can read a full breakdown in How Drive Works.

Ro Sparks

Ro Sparks is a sublingual ED tablet from the telehealth company Ro (formerly Roman). It contains sildenafil and tadalafil in one fixed dose for everyone, listed at checkout as 55mg sildenafil and 22mg tadalafil1. That 22mg runs above tadalafil's 20mg FDA-approved maximum, with no evidence that more adds benefit for ED11. It dissolves under the tongue and has no third active ingredient. Full detail in our Ro Sparks review.

Ro Sparks tablet next to a HELMD Drive sublingual tablet
Start with a quick online visit

A licensed provider reviews your information and decides whether Drive is appropriate for you.

Get Started

The apomorphine difference

PDE5 inhibitors like sildenafil and tadalafil work on the plumbing: they relax blood vessels so more blood can flow to the penis. But an erection also depends on signaling from the brain, and PDE5 inhibitors don't touch that side at all.

Apomorphine does. It's a dopamine agonist that acts centrally, on the brain's arousal pathways. In pooled placebo-controlled trials, sublingual apomorphine produced erections firm enough for intercourse in about half of attempts versus a third on placebo6, 7. A sublingual form of apomorphine was approved in Europe specifically for ED12, 13. We cover what it does, and doesn't do, in Apomorphine for ED.

Ro Sparks addresses blood flow alone. For men whose ED is purely vascular, that may be enough. For men who also experience an arousal component, who have been failed by PDE5s alone, or who want the strongest formulation, HELMD Drive may be a better choice.

One dose vs. two strengths

Ro Sparks uses a single fixed dose for everyone: 55mg sildenafil and 22mg tadalafil1. There's no room to dial it up or down based on how you respond or what you tolerate.

HELMD Drive comes in two strengths, which keeps the treatment decision simple: Drive, and Drive Max for men who need more. That matches the treatment to you rather than the other way around: useful if a standard high dose brings more side effects than you'd like, or if you want a stronger option.

One note on tadalafil: 20mg is the highest FDA-approved dose, and there's no clinical evidence that going above it adds benefit for ED11, so Sparks carrying 22mg isn't an advantage over Drive's 20mg.

Onset & taste

Both are sublingual tablets, which means they dissolve under the tongue and absorb partly through mouth tissue directly into the bloodstream. That bypasses some of the first-pass metabolism a swallowed pill goes through in the liver and leads to faster onset8. In side-by-side testing, both dissolved in about five minutes and kicked in within 15 minutes4, 5. The tadalafil in each supports a long window of effect, up to 24–36 hours of activity. We break down why the delivery route matters in Sublingual vs. chewable vs. swallowed ED meds.

Taste is where testers split: reviewers called Ro Sparks' flavor spicier and more medicinal and described the experience as more mechanical, while HELMD Drive's was more minty and mild4, 5. Drive also contains no artificial colors or dyes.

Availability & cost

HELMD is available across the U.S. except South Carolina. Ro operates as a large nationwide telehealth platform; availability for a specific product like Ro Sparks can depend on your state, so confirm at checkout.

At checkout, Ro Sparks comes to $11.17 per dose on a 3 month plan at 6 doses per month (September 2026)3. On the same plan, HELMD Drive comes to $7.67 per tablet, as low as $6.96 on larger plans3. Even the higher-strength Drive Max starts lower than Sparks: from $10.48 per tablet against Sparks' best price of $10.753. Neither is typically covered by insurance, though FSA/HSA funds may apply.

Who should choose which

On this comparison, HELMD Drive is the stronger choice: the same sublingual format and PDE5 base, plus a third pharmaceutical with placebo-controlled evidence for ED treatment6, 7, a choice of two strengths instead of one fixed dose1, and $7.67 per tablet to Sparks' $11.17 on the same plan3.

As always, the right answer comes from a licensed provider who has reviewed your history - not from a label comparison alone.

Is HELMD Drive a good Ro Sparks alternative?

For men comparing Sparks alternatives, HELMD Drive is the closest sublingual switch: the same two PDE5 inhibitors, plus apomorphine as a third active6, 7.

HELMD Drive adds a choice of two strengths where Ro Sparks has one fixed dose1, and comes to $7.67 per tablet to Sparks' $11.17 on the same plan3. In side-by-side testing both kicked in within 15 minutes; reviewers found Sparks' flavor spicier and more medicinal4, 5. Drive contains no artificial colors or dyes. Read how Drive works or check availability and pricing for your state.

Frequently asked questions

Both are compounded sublingual tablets that dissolve under the tongue. HELMD Drive combines sildenafil, tadalafil, and apomorphine in two strengths; Ro Sparks is sildenafil and tadalafil only, in one fixed dose1.

No. Ro Sparks contains sildenafil and tadalafil only. HELMD Drive adds apomorphine, which acts on the brain's arousal pathways6, 7.

Both are compounded and not FDA-approved. Their PDE5 ingredients are FDA-approved as standalone drugs.

At checkout, Ro Sparks came to $12 per dose billed monthly and $11.17 on a 3 month plan at 6 doses per month; HELMD Drive comes to $7.67 per tablet on the same plan3. Confirm current pricing with each provider.

Editorial standards. HELMD's content is written to be accurate and current and is reviewed by Board-Certified Urologists on the HELMD Medical Advisory Board. Unless otherwise cited, Ro product and pricing details are from Ro's own website and third-party reviews; prices and formulations can change, so confirm at checkout. This article is for informational purposes only, is not medical advice, and is not an endorsement of one brand over another. See a mistake? Email support@helmd.com.
Dr. Bilal Chughtai
Reviewed by Dr. Bilal Chughtai, MD
Urologist, functional urology & men's health · HELMD Medical Advisory Board

Dr. Chughtai is a Board-Certified Urologist and the author of 160+ peer-reviewed publications, with fellowship training at Weill Cornell.

Read full bio →

Sources

  1. Ro. Sparks product page and checkout (sublingual; onset and pricing claims; 55mg sildenafil / 22mg tadalafil shown at checkout, reviewed October 2026). ro.co
  2. U.S. Food & Drug Administration. Compounding and the FDA: Questions and Answers. fda.gov
  3. HELMD and Ro checkout pricing (both brands' own checkouts), monthly and 3 month plans, retrieved September and October 2026. helmd.com
  4. The Customer Digest. Best combo ED med 2026: we tested HELMD Drive (Drive named top pick; Sparks dissolve and onset times, taste, per-dose pricing). thecustomerdigest.com
  5. Protocol Man. Best combo ED med 2026: five treatments tested (Drive named top pick; Sparks onset, taste, per-dose pricing). protocolman.com
  6. Dula E, Keating W, Siami PF, et al; The Apomorphine Study Group. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. Urology. 2000;56(1):130-135. pubmed.ncbi.nlm.nih.gov
  7. Stief C, Padley RJ, Perdok RJ, Sleep DJ. Cross-study review of the clinical efficacy of apomorphine SL 2 and 3 mg: pooled data from three placebo-controlled, fixed-dose crossover studies. Eur Urol Suppl. 2002;1(3):12-20. europeanurology.com
  8. Deveci S, Peşkircioğlu L, Aygün C, et al. Sublingual sildenafil in the treatment of erectile dysfunction: faster onset of action with less dose. Int J Urol. 2004;11(11):989-992. pubmed.ncbi.nlm.nih.gov
  9. Dhaliwal A, Gupta M. PDE5 Inhibitors. In: StatPearls [Internet]. StatPearls Publishing; 2023 (first-line status). ncbi.nlm.nih.gov
  10. Cui H, Liu B, Song Z, et al. Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction. Andrologia. 2015;47(1):20-24. onlinelibrary.wiley.com
  11. U.S. Food & Drug Administration. CIALIS (tadalafil) prescribing information (20 mg maximum approved dose). accessdata.fda.gov
  12. European Medicines Agency. Uprima (apomorphine hydrochloride): EU marketing authorisation for erectile dysfunction, granted May 28, 2001. ema.europa.eu
  13. Altwein JE, Keuler FU. Oral treatment of erectile dysfunction with apomorphine SL. Urol Int. 2001;67(4):257-263. pubmed.ncbi.nlm.nih.gov